DENTSPLY SIRONA (NASDAQ:XRAY) Research Coverage Started at Guggenheim

Guggenheim began coverage on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research note released on Wednesday, April 17th, FirstToMarketsRatingsTable reports. The brokerage issued a neutral rating and a $54.00 price target on the medical instruments supplier’s stock.

Several other brokerages have also issued reports on XRAY. Barclays restated a hold rating and set a $39.00 price target on shares of DENTSPLY SIRONA in a research note on Sunday, January 6th. BidaskClub upgraded DENTSPLY SIRONA from a hold rating to a buy rating in a research note on Tuesday, December 25th. William Blair upgraded DENTSPLY SIRONA from a market perform rating to an outperform rating and set a $56.71 price target on the stock in a research note on Monday, March 18th. Zacks Investment Research upgraded DENTSPLY SIRONA from a strong sell rating to a hold rating in a research note on Sunday, January 6th. Finally, HC Wainwright set a $49.00 price target on DENTSPLY SIRONA and gave the company a hold rating in a research note on Friday, April 5th. Nine research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of $53.25.

Shares of NASDAQ:XRAY opened at $54.99 on Wednesday. DENTSPLY SIRONA has a fifty-two week low of $33.93 and a fifty-two week high of $55.88. The company has a quick ratio of 1.27, a current ratio of 1.86 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $12.19 billion, a price-to-earnings ratio of 27.36, a P/E/G ratio of 2.25 and a beta of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. DENTSPLY SIRONA had a positive return on equity of 8.98% and a negative net margin of 26.48%. The business had revenue of $946.20 million during the quarter, compared to analysts’ expectations of $925.13 million. During the same quarter in the previous year, the firm earned $0.45 EPS. The firm’s revenue was down 1.0% compared to the same quarter last year. As a group, analysts predict that DENTSPLY SIRONA will post 2.33 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a $0.087 dividend. The ex-dividend date was Thursday, March 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio is currently 17.41%.

In other news, insider Markus Boehringer sold 25,300 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $54.83, for a total value of $1,387,199.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Daniel P. Key purchased 3,697 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were acquired at an average price of $54.68 per share, for a total transaction of $202,151.96. Following the completion of the transaction, the senior vice president now owns 9,024 shares in the company, valued at $493,432.32. The disclosure for this purchase can be found here. Corporate insiders own 0.62% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Private Capital Group LLC grew its position in DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 359 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. bought a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Pinnacle Bank bought a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Truehand Inc bought a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $27,000. Finally, Enlightenment Research LLC bought a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $30,000. Institutional investors and hedge funds own 99.78% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Why is total return important?

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.